SCHEMBL16149256

SCHEMBL16149256

CC(=O)C(CN)c1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.46
GABBR1 Q9UBS5 1/20 0.46
AOC3 Q16853 2/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
ROCK2 O75116 2/20 0.43
ROCK1 Q13464 1/20 0.43
MYLK4 Q86YV6 1/20 0.43
HTT P42858 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22304942 0.82 ESR1 (0.65) ESR1ESR2ROCK2
SCHEMBL3384110 0.82 GABBR2 (0.47) GABBR2GABBR1AOC3ROCK2ROCK1
SCHEMBL4733307 0.81 ESR1 (0.44) AOC3ESR1ESR2HTTHDAC3
SCHEMBL684580 0.81 CYP1A2 (0.48) ESR1ESR2
Hydrochloric Acid SCHEMBL21631913 0.81 GABBR2 (0.46) GABBR2GABBR1AOC3ROCK2ROCK1
SCHEMBL8217885 0.81 BRD4 (0.53) GABBR2GABBR1AOC3ESR1ESR2
SCHEMBL24244773 0.80 ROCK2 (0.43) GABBR2GABBR1AOC3ROCK2ROCK1
SCHEMBL21656311 0.80 ESR1 (0.49) GABBR2GABBR1AOC3ESR1ESR2
SCHEMBL637485 0.80 GABBR2 (0.50) GABBR2GABBR1ESR1ESR2
SCHEMBL12167861 0.79 ESR1 (0.51) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970298-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2016-01-20 EP disclosed
WO-2014164467-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2014-10-09 WO disclosed